Optiver Holding
CAPR icon

Optiver Holding’s Capricor Therapeutics CAPR Stock Holding History

Optiver Holding’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.06K Sell
265
-36
-12% -$959 ﹤0.01% 1271
2025
Q4 		$8.69K Sell
301
-37
-11% -$483 ﹤0.01% 1179
2025
Q3 		$2.44K Buy
+338
New +$2.49K ﹤0.01% 2305

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Optiver Holding's CAPR Position: Q1 2026 in Review

Optiver Holding reduced its Capricor Therapeutics (CAPR) stake by 12% in Q1 2026, selling an estimated $959 and leaving 265 shares worth $8.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1271.

Optiver Holding first reported a position in CAPR in Q3 2025 and has held it in 3 quarters since. The position peaked at $8.69K in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Optiver Holding held 265 shares of Capricor Therapeutics worth $8.06K as of Q1 2026.
  • Optiver Holding sold 36 Capricor Therapeutics shares in Q1 2026, an estimated $959.
  • Capricor Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1271 holding.
  • Optiver Holding first reported a position in Capricor Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Capricor Therapeutics position peaked at $8.69K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.